Promising early results from vaccine trials give hope to defeat Covid-19, but vaccines may be less effective in the real world and people’s safety concerns could hamper uptake
health
| leader
18th November 2020
What a difference a week makes. It was around this time that we moved from hoping a coronavirus vaccine would work to promising results from not one but three studies.
When last week’s edition went to press, we had just heard news that a vaccine candidate appears to be safe and effective in late-stage human studies – at least based on interim results. That was the vaccine from the US company Pfizer and its German partner BioNTech. Then came the results – albeit in a smaller sample – of the Russian vaccine Sputnik V. And on Monday the US company Moderna …
You may also like
New Bariatric Portion Plate Helps Bariatric Patients Reach Their Goals
2021 preview: how soon will a Covid-19 vaccine normalize life?
Official British statisticians had concerns about the trend in the Covid-19 poll
NASA’s probe on Mars may feel the ground shake when rovers land in 2021
International Study Shows This Brain Supplement Reverses Years of Mental Decline and May Also Reduce the Risk of Dementia